Eli Lilly's 2015 Guidance Shows That Zoetis (ZTS) is Undervalued - BMO Capital
Tweet Send to a Friend
BMO Capital analyst Alex Arfaei said Eli Lilly's 2015 guidance suggests Zoetis Inc. (NYSE: ZTS) deserves a premium valuation."Based on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
